Huntington’s disease trial test is ‘major advance’ Cath Stanley, chief executive of Hungtington’s Disease Association, said: “This is a ground breaking piece of research that takes nearer to having a better understanding about Huntington’s disease.”
They found levels of the brain protein were high in people with Huntington’s disease and were even elevated in people who carried the gene for Huntington’s disease but were many years away from showing any symptoms.
Huntington’s disease is an inherited and incurable brain disorder that is currently fatal.
They added: “The study represents a major advance in the field of Huntington’s disease and neurodegeneration in general…”But they cautioned that it was important to carry out further, larger trials to confirm the results.
Image copyright SPLScientists say they may have found the world’s first blood test that predicts when someone at risk is likely to get Huntington’s disease and tracks how quickly damage to the brain occurs.
as declared in Credit: Wikipedia/ Creative Commons Attribution 3.0 Unported license The first blood test that can predict the onset and progression of Huntington’s disease has been identified by a UCL-led study.
A montage of three images of single striatal neurons transfected with a disease-associated version of huntingtin, the protein that causes Huntington’s disease.
Dr Robert Pacifici, chief scientific officer of CHDI Foundation, a US non-profit Huntington’s disease research foundation, welcomed the development.
“Neurofilament has the potential to serve as a speedometer in Huntington’s disease, since a single blood test reflects how quickly the brain is changing.
“This is the first time a potential blood biomarker has been identified to track Huntington’s disease so strongly,” said the study’s senior author, Dr Edward Wild (UCL Institute of Neurology).
as declared in
Blood test can predict onset and track progression of Huntington’s disease
as declared in A simple blood test could predict Huntingdon’s disease years before its onset, in a breakthrough which could one day lead to the first treatment for the incurable condition.
More than 10,000 people in the UK suffer from the disease which is fatal and currently incurable.
Research by University College London said they have identified the strongest potential blood biomarker yet which can identify and track the genetic brain disorder.
This content may collect you by Emily Henry